Data as of Nov 5, 2026
66.232.217.0/24
No anonymizer space · no proxy exits in 30 daysEagle Communications, Inc.
Announcements
Less specific
Covering announcements
| Prefix | Origin | Type | Proxy exits | Holder | RPKI |
|---|---|---|---|---|---|
| 66.232.192.0/19 since Sep 2024 | AS35986 | Residential | 88 14 always on | Eagle Communications, Inc. |
Registrations in this block
The registry's network records over the announcement: those covering it, widest first, then every record inside it, under its parent.
| Range | Addresses | Netname | Holder | Type | Created | Abuse contact |
|---|---|---|---|---|---|---|
| 66.232.192.0/19 | 8,192 | EAGLENET | Eagle Communications, Inc. (EAGLE-9) · US | Direct Allocation | Apr 1, 2003 | abuse@ |
| └ 66.232.217.0/24 | 256 | EAGLENET-KANED | Eagle Communications, Inc. (EAGLE-9) · US | Reassigned | Dec 19, 2005 | abuse@ |
Network & registry
Registry
Holder
- Organization
- Eagle Communications, Inc.
- Handle
- EAGLE-9
- Range
- 66.
232. 192. 0/ 19 - Registration type
- Direct Allocation
- Record created
- Apr 1, 2003
Origin network
AS30612
US
- Name
- Eagle Communications, Inc.
- Type
- Internet provider
- Registered
- Nov 19, 2003
- Domain
- eaglecom.net
- Industry
- Computer and Information Technology
- Spamhaus ASN-DROP
- not listed
Routing timeline
Covering aggregate above, the prefix's own history below
Summary
Routing history
- Pattern
- Stable
- First seen
- Sep 2024
- Current origin since
- Sep 2024 · 2.2 yr
- Origin networks
- 1
Whois
Registration for this announcement
- Range
- 66.
232. 217. 0/ 24 - Netname
- EAGLENET-KANED
- Registrant
- Eagle Communications, Inc.
- Organization
- Eagle Communications, Inc. (EAGLE-9)
- Org address
- 1617 16th St, Central City, NE, 68826
- Org country
- US
- Type
- Reassigned
- Handle
- NET-66-232-217-0-1
- Parent
- NET-66-232-192-0-1
- Created
- Dec 19, 2005
- RIR
- ARIN
- Country
- US
- Delegated
- Apr 1, 2003
- Status
- assigned
Report abuse
Abuse contact
- abuse@
vyvebb. com - Name
- Vyve-Abuse
- Phone
- +1-855-367-8983
- Handle
- VYVEA1-ARIN